Tod M Klingler PhD

Dr. Tod Klingler is the head of product research, development, and management. 
 
Over his 25-year career, Dr. Klingler has held leadership roles with organizations that have successfully developed and commercialized innovative products that advance the understanding of biology and improve human health including Illumina, Roche, XDx (now CareDx) and Incyte. Applying his expertise in advanced genomics and informatics technologies, Dr. Klingler has also founded start-up companies such as Prospect Genomics and Station X. 
 
Dr. Klingler received his undergraduate degrees and PhD from Stanford University. 
 
Tod is passionate about bringing the advances of genomics that improve human health to everyone, as well as propelling organizations forward to deliver on that mission.